No dose-ranging trial was ever performed and DSIP is not approved for any indication
But what happens deeper down
Subcutaneous peptide delivery relies on consistent depot formation in the hypodermis
[DOI] [PubMed] [Google Scholar] 11.Sikiric P., Seiwerth S., Rucman R., Turkovic B., Brcic L., Sever M., Klicek R., Radic B., Drmic D., Ilic S., et al
Shu Taishen (300204.SZ): STSA-1301 subcutaneous injection (primary immune thrombocytopenia ITP) phase Ia clinical trial completed the administration of the first case of subjects: moomoo
Scope-of-practice requirements vary by license type physicians can typically practice independently, while NPs and PAs may require collaborative agreements depending on state regulations